Department of Pathology, Chonnam National University Research Institute of Medical Science, Chonnam National University Medical School and Hwasun Hospital, Jeollanam-do, Republic of Korea.
Department of Pharmacology and Toxicology, Sylhet Agricultural University, Sylhet, Bangladesh.
Anticancer Res. 2021 Jul;41(7):3349-3361. doi: 10.21873/anticanres.15123.
BACKGROUND/AIM: The present study investigated the oncogenic functions of TACC3 in the progression of gastric cancer (GC).
We analysed TACC3 in relation to cell growth, invasion capability, expression of epithelial-mesenchymal transition (EMT)-related markers, and ERK/Akt/cyclin D1 signaling factors. The correlation between the immunohistochemically confirmed expression of TACC3 and clinical factors was also analyzed.
The increased proliferation and invasion of TACC3-over-expressing GC cells was accompanied by altered regulation of EMT-associated markers and activation of ERK/Akt/cyclin D1 signaling. Immunohistochemical analysis of TACC3 in human GC tissues revealed that its expression is correlated with aggressive characteristics and poor prognosis of intestinal-type GC.
TACC3 contributes to gastric tumorigenesis by promoting EMT via the ERK/Akt/cyclin D1 signaling pathway. The correlation between TACC3 expression and multiple clinicopathological variables implies that its effective therapeutic targeting in GC will depend on the tumor subtype.
背景/目的:本研究旨在探讨 TACC3 在胃癌(GC)进展中的致癌功能。
我们分析了 TACC3 与细胞生长、侵袭能力、上皮-间充质转化(EMT)相关标志物表达以及 ERK/Akt/细胞周期蛋白 D1 信号因子之间的关系。还分析了免疫组织化学证实的 TACC3 表达与临床因素之间的相关性。
过表达 TACC3 的 GC 细胞的增殖和侵袭增加伴随着 EMT 相关标志物的调节改变和 ERK/Akt/细胞周期蛋白 D1 信号通路的激活。对人 GC 组织中 TACC3 的免疫组织化学分析表明,其表达与肠型 GC 的侵袭性特征和不良预后相关。
TACC3 通过 ERK/Akt/细胞周期蛋白 D1 信号通路促进 EMT 促进胃肿瘤发生。TACC3 表达与多种临床病理变量之间的相关性表明,其在 GC 中的有效治疗靶点将取决于肿瘤亚型。